| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT03212352 Details | 2020-05-01 Interventional | 4 | 342 | Mifepristone Misoprostol Early Pregnancy… | Advised by DSMB based on interim-analysis, highly significant difference. - | |||
| NCT03015831 Details | 2020-05-01 Interventional | 3 | 254 | Colchicine Atrial Fibrilla… Cardiac Surgery Colchicine Adve… | Statistical analysis of interim data showed no advantage of colchicine - | |||
| NCT00092287 2004-001091-40 Details | 2020-04-30 Interventional | 3 | 4 | Lanreotide Octreotide Somatostatin Carcinoid Tumor Malignant Carci… Serotonin Syndr… Syndrome | - - | |||
| NCT03400254 Details | 2020-04-28 Interventional | 1/2 | 0 | Gedatolisib Hydroxychloroqu… Breast Neoplasm… Breast Cancer | due to business decision regarding the study drug. - | |||
| NCT03378973 Details | 2020-04-28 Interventional | 4 | 7 | Dexmedetomidine Spinal Fusion | No longer clinically relevant - | |||
| NCT02400645 Details | 2020-04-28 Interventional | 1 | 69 | Bupivacaine Ketorolac Pain, Postopera… Postoperative P… | It was determined that one member of the team had falsified data. - | |||
| NCT00003645 Details | 2020-04-28 Interventional | 3 | 64 | Bicalutamide Flutamide Goserelin Leuprolide Prostatic Neopl… Recurrence Prostate Cancer | Per PI request - | |||
| NCT00632827 Details | 2020-04-27 Interventional | 2 | 21 | Carmustine Cyclophosphamid… Cytarabine Denileukin dift… Doxorubicin Etoposide Gemcitabine Lenograstim Leucovorin Liposomal doxor… Methotrexate Vincristine Vinorelbine Lymphoma Lymphoma, T-Cel… Lymphoma, T-Cel… Peripheral T-Ce… | Manufacturing shortage of both Diftitox and Doxil Enrollment was terminated prematurely due to manufacturing shortages of Doxil and Denileukin Diftitox (Ontak). All eligible patients who received at least one dose of study regimen were included in the analyses | |||
| NCT00433342 Details | 2020-04-27 Interventional | 1 | 9 | Floxacillin Kidney Diseases Renal Insuffici… Chronic Kidney … | - - | |||
| NCT03920839 Details | 2020-04-24 Interventional | 1 | 0 | Carboplatin Gemcitabine Paclitaxel Pemetrexed Carcinoma, Non-… Mesothelioma Mesothelioma, M… Advanced and/or… Advanced/Metast… Stage IIIB Not … | As of November 4, 2019 the study was halted prematurely and will not resume. - | |||
| NCT02452775 Details | 2020-04-24 Interventional | 1 | 3 | Monatide (IMS 3… Poly ICLC Carcinoma, Ovar… Fallopian Tube … Ovarian Neoplas… Fallopian Tube … Primary Ovarian… Primary Periton… | - - | |||
| NCT01312376 Details | 2020-04-24 Interventional | 1 | 18 | Bevacizumab Cyclophosphamid… Fludarabine Vaccines Fallopian Tube … Fallopian Tube … Ovarian Carcino… Primary Periton… | - - | |||
| NCT03949842 Details | 2020-04-22 Interventional | 4 | 0 | Adrenergic Agen… Cholinergic Age… Fluticasone Muscarinic Anta… Xhance Lung Diseases Pulmonary Disea… | The decision to end the study was based on a change in GSK strategy. No subjects were enrolled
into the study. - | |||
| NCT03507374 Details | 2020-04-21 Interventional | 1 | 20 | Alirocumab Atherosclerosis Hemorrhage Intracranial Ar… Intracranial At… Intraplaque Hem… Stroke | Funding withdrawn - | |||
| NCT03075553 Details | 2020-04-21 Interventional | 2 | 12 | Nivolumab Enteropathy-Ass… Immunoblastic L… Intestinal Dise… Leukemia Leukemia, T-Cel… Leukemia-Lympho… Lymphoma Lymphoma, Extra… Lymphoma, Large… Lymphoma, Non-H… Lymphoma, T-Cel… Lymphoma, T-Cel… Mycoses Mycosis Fungoid… Recurrence Blastic Plasmac… HTLV-1 Infectio… Hepatosplenic T… NK-Cell Lymphom… Primary Systemi… Recurrent Adult… Recurrent Anapl… Recurrent Angio… Recurrent Enter… Recurrent Mycos… Refractory Adul… Refractory Anap… Refractory Angi… Refractory Ente… Refractory Myco… Refractory Nasa… Refractory Peri… | due to poor response - | |||
| NCT00776373 Details | 2020-04-21 Interventional | 1/2 | 4 | Cytarabine Etoposide Sirolimus Burkitt Lymphom… Leukemia Leukemia, Lymph… Lymphoma Precursor Cell … ALL Burkitt's Lymph… CML Lymphoblastic L… | - - | |||
| NCT03381859 Details | 2020-04-20 Interventional | 4 | 0 | Elbasvir-grazop… Grazoprevir Communicable Di… Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… Infections Hepatitis C Vir… | HCV treatment expansion occurred in Egypt - | |||
| NCT01998828 2013-004105-11 Details | 2020-04-20 Interventional | 2 | 39 | N-(cyanomethyl)… Polycythemia Polycythemia Ve… Thrombocythemia… Thrombocytosis Essential Throm… | - - | |||
| NCT02265510 Details | 2020-04-17 Interventional | 1/2 | 83 | Azacitidine Bortezomib Dexamethasone Gemcitabine Lenalidomide Paclitaxel Pomalidomide Neoplasms Advanced Malign… Metastatic Canc… Solid Tumors | - - | |||
| NCT02020278 Details | 2020-04-17 Interventional | 3 | 3 | Tolvaptan Hyponatremia | Issues with recruitment and enrollment made the trial impossible or highly impracticable.
Termination of this trial was not due to safety reasons. This trial was prematurely terminated due to challenges in enrollment. The trial was not terminated due to safety reasons. Due to early termination of the study, no efficacy data were collected. |